Comparison of the effect of teicoplanin and vancomycin on experimental methicillin-resistant staphylococcus aureus keratitis

被引:6
作者
Ucgul, Ahmet Yucel [1 ]
Behcet, Mustafa [2 ]
机构
[1] Abant Izzet Baysal Univ, Training & Res Hosp, Dept Ophthalmol, Kilicarslan Mah 144,Sk 7-6 Merkez, Bolu, Turkey
[2] Abant Izzet Baysal Univ, Training & Res Hosp, Dept Med Microbiol, Bolu, Turkey
关键词
Keratitis; Methicillin-resistant staphylococcus aureus; Teicoplanin; Vancomycin;
D O I
10.1007/s10792-021-01696-2
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose To evaluate the early efficacy and safety of intrastromal injection of teicoplanin as the alternative treatment for the methicillin-resistant Staphylococcus aureus (MRSA) keratitis by comparing it with vancomycin. Materials and methods Twenty-four eyes of 24 New Zealand white rabbits were included in the study. MRSA keratitis was induced in the right eye of each rabbit by injecting 0.1 mL MRSA suspension containing 1000 colony-forming units (CFU) intrastromally to the central cornea. The rabbits were divided into three treatment groups 24 h after the inoculation of MRSA. Eight rabbits received intrastromal teicoplanin therapy, eight received intrastromal vancomycin therapy, and eight received balanced salt solution and served as the control group. Nine hours after the treatment, all rabbits were sacrificed and corneal tissues were collected for microbiological analysis. We also examined and scored all the rabbits clinically before and after the treatment. Results The control group scored higher with regard to conjunctival injection, iritis, fibrin, hypopyon, epithelial erosion, and corneal infiltrate than the vancomycin and teicoplanin groups (p = 0.031, 0.010, < 0.001, 0.029, 0.009, and < 0.001, respectively). Chemosis and corneal oedema were similar in all groups (p = 0.731 and 0.075, respectively). The severity of all clinical parameters was similar in both the vancomycin and teicoplanin groups after the treatment. The bacterial load was the highest (7.83 +/- 0.71 log(10) CFU/g) in the control group. The eyes treated with vancomycin and teicoplanin had similar bacterial loads (6.40 +/- 0.69 vs. 6.31 +/- 0.75 log(10) CFU/g, p = 0.809). Conclusion The efficiency of teicoplanin seems to be comparable to that of vancomycin when administered intrastromally in the early treatment of MRSA keratitis. The former may be preferred in the treatment of selected cases with vancomycin hypersensitivity or resistance.
引用
收藏
页码:1395 / 1402
页数:8
相关论文
共 24 条
[1]   Intravitreal penetration of teicoplanin [J].
Briggs, MC ;
McDonald, P ;
Bourke, R ;
Smith, G ;
McGalliard, JN ;
Wong, D .
EYE, 1998, 12 (2) :252-255
[2]   Comparing the ocular surface effects of topical vancomycin and linezolid for treating bacterial keratitis [J].
Budak, Berna Akova ;
Baykara, Mehmet ;
Kivanc, Sertac Argun ;
Yilmaz, Hakan ;
Cicek, Serhat .
CUTANEOUS AND OCULAR TOXICOLOGY, 2016, 35 (02) :126-130
[3]   In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria [J].
Citron, DM ;
Merriam, CV ;
Tyrrell, KL ;
Warren, YA ;
Fernandez, H ;
Goldstein, EJC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (07) :2334-2338
[4]   Vancomycin resistant Staphylococcus aureus infections: A review of case updating and clinical features [J].
Cong, Yanguang ;
Yang, Sijin ;
Rao, Xiancai .
JOURNAL OF ADVANCED RESEARCH, 2020, 21 :169-176
[5]   Methicillin-Resistant Staphylococcus aureus Keratitis: Initial Treatment, Risk Factors, Clinical Features, and Treatment Outcomes [J].
Durrani, Asad F. ;
Atta, Sarah ;
Bhat, Amar K. ;
Mammen, Alex ;
Dhaliwal, Deepinder ;
Kowalski, Regis P. ;
Jhanji, Vishal .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2020, 214 :119-126
[6]   Treatment-Resistant Bacterial Keratitis: Challenges and Solutions [J].
Egrilmez, Sait ;
Yildirim-Theveny, Seyda .
CLINICAL OPHTHALMOLOGY, 2020, 14 :287-297
[7]   A Nine-Year Analysis of Practice Patterns, Microbiologic Yield, and Clinical Outcomes in Cases of Presumed Infectious Endophthalmitis [J].
Feng, Henry L. ;
Robbins, Cason B. ;
Fekrat, Sharon .
OPHTHALMOLOGY RETINA, 2020, 4 (06) :555-559
[8]   TOPICAL VANCOMYCIN FORMULATION FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS-EPIDERMIDIS BLEPHAROCONJUNCTIVITIS [J].
FLEISCHER, AB ;
HOOVER, DL ;
KHAN, JA ;
PARISI, JT ;
BURNS, RP .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1986, 101 (03) :283-287
[9]  
Flynn HW, 2018, IN CLIN PRACT, P123, DOI 10.1007/978-3-319-66351-7_5
[10]   New Therapy Option for Treatment of Methicillin-Resistant Staphylococcus aureus Keratitis: Tigecycline [J].
Goktas, Sertan ;
Kurtoglu, Muhammet Guzel ;
Sakarya, Yasar ;
Ugurluoglu, Ceyhan ;
Ozcimen, Muammer ;
Sakarya, Rabia ;
Alpfidan, Ismail ;
Ivacik, Ismail Senol ;
Erdogan, Erkan ;
Bukus, Abdulkadir .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2015, 31 (02) :122-127